• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease.

作者信息

Freedman R R, Baer R P, Mayes M D

机构信息

Department of Psychiatry (Cellular and Clinical Neurobiology), Wayne State University School of Medicine, Detroit, Mich., USA.

出版信息

Circulation. 1995 Sep 15;92(6):1448-51. doi: 10.1161/01.cir.92.6.1448.

DOI:10.1161/01.cir.92.6.1448
PMID:7664425
Abstract

BACKGROUND

Idiopathic Raynaud's disease is characterized by cold-induced digital vasospasms, but its origin has not been established. Previous research has shown that peripheral vascular alpha 2-adrenergic receptors are hypersensitive to local cooling in these patients, but the role of alpha 1-adrenergic receptors is not clear. Moreover, the role of adrenergic receptors in the production of actual vasospastic symptoms has not been investigated.

METHODS AND RESULTS

We studied 23 patients with idiopathic Raynaud's disease who were screened using conservative criteria. They were randomly assigned to receive brachial artery infusions of an alpha 1-antagonist, an alpha 2-antagonist, or both while vasospastic attacks were induced by cooling in the laboratory. Each patient's hands were photographed, and the number of attacks in the infused hand was compared with the number in the contralateral hand. The number of fingers (mean +/- SEM) with attacks in infused hands was yohimbine 0.3 +/- 0.3, prazosin 2.3 +/- 0.3, and both drugs 0.6 +/- 0.2. The difference between prazosin and the other two drug groups was significant (P < .001).

CONCLUSIONS

These findings demonstrate that activation of alpha 2-adrenergic receptors but not alpha 1-adrenergic receptors is necessary for the production of vasospastic attacks in idiopathic Raynaud's disease.

摘要

相似文献

1
Blockade of vasospastic attacks by alpha 2-adrenergic but not alpha 1-adrenergic antagonists in idiopathic Raynaud's disease.
Circulation. 1995 Sep 15;92(6):1448-51. doi: 10.1161/01.cir.92.6.1448.
2
Role of digital artery adrenoceptors in Raynaud's disease.数字动脉肾上腺素能受体在雷诺病中的作用。
Vasc Med. 1997;2(1):1-7. doi: 10.1177/1358863X9700200101.
3
Cold-induced potentiation of alpha 2-adrenergic vasoconstriction in primary Raynaud's disease.
Arthritis Rheum. 1993 May;36(5):685-90. doi: 10.1002/art.1780360517.
4
Induction of vasospastic attacks despite digital nerve block in Raynaud's disease and phenomenon.尽管在雷诺病和雷诺现象中进行了指神经阻滞,但仍诱发血管痉挛发作。
Circulation. 1989 Oct;80(4):859-62. doi: 10.1161/01.cir.80.4.859.
5
Raynaud's phenomenon. An update.雷诺现象。最新进展。
Hypertension. 1991 May;17(5):593-602. doi: 10.1161/01.hyp.17.5.593.
6
[Raynaud's phenomenon: effects of terazosin].[雷诺现象:特拉唑嗪的作用]
Minerva Cardioangiol. 1997 May;45(5):215-21.
7
Mechanisms of Raynaud's disease.雷诺氏病的发病机制。
Vasc Med. 2005 Nov;10(4):293-307. doi: 10.1191/1358863x05vm639ra.
8
Pathogenesis and treatment of Raynaud's phenomenon.
Cardiovasc Drugs Ther. 1990 Jan;4 Suppl 1:45-51. doi: 10.1007/BF00053426.
9
Yohimbine antagonises α1A- and α1D-adrenoceptor mediated components in addition to the α2A-adrenoceptor component to pressor responses in the pithed rat.育亨宾拮抗α1A-和α1D-肾上腺素受体介导的成分,除了α2A-肾上腺素受体成分,以加压反应在被切断脑的大鼠。
Eur J Pharmacol. 2012 Mar 15;679(1-3):90-4. doi: 10.1016/j.ejphar.2012.01.001. Epub 2012 Jan 21.
10
Prazosin treatment of primary Raynaud's phenomenon.哌唑嗪治疗原发性雷诺现象。
Eur J Clin Pharmacol. 1983;24(3):421-3. doi: 10.1007/BF00610065.

引用本文的文献

1
Skin transient receptor potential channels expression and microvascular reactivity to cooling in primary and secondary Raynaud's phenomenon.原发性和继发性雷诺现象中皮肤瞬时受体电位通道的表达及微血管对冷却的反应性
Physiol Rep. 2025 Sep;13(17):e70557. doi: 10.14814/phy2.70557.
2
α2 adrenoceptors, cold-induced vasoconstriction, and Raynaud's phenomenon.α2肾上腺素能受体、冷诱导的血管收缩与雷诺现象。
Cell Genom. 2025 May 14;5(5):100884. doi: 10.1016/j.xgen.2025.100884.
3
Genetic and functional analysis of Raynaud's syndrome implicates loci in vasculature and immunity.
雷诺氏综合征的遗传和功能分析提示血管和免疫部位的相关基因。
Cell Genom. 2024 Sep 11;4(9):100630. doi: 10.1016/j.xgen.2024.100630. Epub 2024 Aug 13.
4
Adrenoceptors and Hypertension.肾上腺素能受体与高血压。
Handb Exp Pharmacol. 2024;285:297-332. doi: 10.1007/164_2024_719.
5
ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon.ADRA2A 和 IRX1 是雷诺现象的潜在风险基因。
Nat Commun. 2023 Oct 12;14(1):6156. doi: 10.1038/s41467-023-41876-5.
6
Current Concepts on the Pathogenesis of Systemic Sclerosis.系统性硬化症发病机制的现代概念。
Clin Rev Allergy Immunol. 2023 Jun;64(3):262-283. doi: 10.1007/s12016-021-08889-8. Epub 2021 Sep 6.
7
Raynaud's phenomenon.雷诺现象。
Clin Med (Lond). 2020 Nov;20(6):580-587. doi: 10.7861/clinmed.2020-0754.
8
Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.雷诺现象:潜在机制的简要综述
Front Pharmacol. 2016 Nov 16;7:438. doi: 10.3389/fphar.2016.00438. eCollection 2016.
9
Molecular determinants of the human α2C-adrenergic receptor temperature-sensitive intracellular traffic.人类α2C-肾上腺素能受体温度敏感性细胞内转运的分子决定因素。
Mol Pharmacol. 2015 May;87(5):792-802. doi: 10.1124/mol.114.096198. Epub 2015 Feb 13.
10
A vascular mechanistic approach to understanding Raynaud phenomenon.从血管机制角度理解雷诺现象。
Nat Rev Rheumatol. 2015 Mar;11(3):146-58. doi: 10.1038/nrrheum.2014.195. Epub 2014 Dec 23.